Alembic Pharma up 3%, gets tentative USFDA nod for ANDA
Wednesday, April 19, 2017, 11:27 AM
Shares of Alembic Pharmaceuticals advanced 3 percent intraday Wednesday as it has received tentative approval from USFDA for Vilazodone Hydrochloride tablets. “The company has received tentative approval from United States Food and Drug Administration for its ANDA for Vilazodone Hydrochloride tablets, 10 mg, 20 mg and 40 mg," as per company release. Vilazodone Hydrochloride tablets are indicated for the treatment of major depressive disorder.